http://sutent.legalview.com/msn/ 2012-02-23 http://sutent.legalview.com/msn/pipeline-review-bristol-myers-squibbs-5-keys-to-success/1234106/ 2012-02-23 http://sutent.legalview.com/msn/chemo-for-cancer-patients-with-hiv-may-change/1234105/ 2012-02-23 http://sutent.legalview.com/msn/sector-wrap-technology-pharmaceuticals/1234104/ 2012-02-23 http://sutent.legalview.com/msn/pfizer-failure-clears-way-for-small-biotech-arqule/1234103/ 2012-02-23 http://sutent.legalview.com/msn/pivotal-phase-iii-trial-of-novartis-drug-afinitor-met-primary-endpoint/1196065/ 2012-02-23 http://sutent.legalview.com/msn/bevacizumab-linked-to-increased-risk-for-high-grade-proteinuria-and-ne/1196064/ 2012-02-23 http://sutent.legalview.com/msn/cancer-patients-cant-wait-a-year-for-drugs-cash/1196063/ 2012-02-23 http://sutent.legalview.com/msn/consortium-seeks-best-treatment-for-hiv-positive-cancer-patients/1196062/ 2012-02-23 http://sutent.legalview.com/msn/argos-therapeutics-presents-positive-phase-2-data-for-arcelistm-dendri/1196061/ 2012-02-23 http://sutent.legalview.com/msn/chemotherapy-drug-sunitinib-promising-for-hiv-positive-cancer-patients/1196060/ 2012-02-23 http://sutent.legalview.com/msn/argos-therapeutics-presents-positive-phase-2-data-for-arcelis-dendriti/1196059/ 2012-02-23 http://sutent.legalview.com/msn/kidney-damage-affirmed-with-biologic-chemo-combo/1196058/ 2012-02-23 http://sutent.legalview.com/msn/cancer-meetings-winners-and-losers/1196057/ 2012-02-23 http://sutent.legalview.com/msn/seeking-the-best-treatment-for-hiv-positive-cancer-patients/1196056/ 2012-02-23 http://sutent.legalview.com/msn/how-pfizers-pain-could-be-your-gain/1196055/ 2012-02-23 http://sutent.legalview.com/msn/pfizer-drug-targets-gene-flaw-to-shrink-lung-tumors-update1/1196054/ 2012-02-23 http://sutent.legalview.com/msn/what-happened-at-asco-over-the-weekend/1196053/ 2012-02-23 http://sutent.legalview.com/msn/people-on-hiv-meds-might-need-different-chemo-doses-for-cancer/1196052/ 2012-02-23 http://sutent.legalview.com/msn/hormone-refractory-prostate-cancer-new-studies-in/1158434/ 2012-02-23 http://sutent.legalview.com/msn/life-saving-cancer-drugs-still-not-available-on-nhs/1158433/ 2012-02-23 http://sutent.legalview.com/msn/drugs-medications-avastin-iv/1131346/ 2012-02-23 http://sutent.legalview.com/msn/a-case-of-adult-metastatic-xp11-translocation-renal-cell-carcinoma/1131345/ 2012-02-23 http://sutent.legalview.com/msn/tolerance-of-sunitinib-in-dialyzed-patients-with-metastatic-renal-cell/1131344/ 2012-02-23 http://sutent.legalview.com/msn/ziopharm-presents-positive-palifosfamide-sarcoma-randomized-phase-ii/1131343/ 2012-02-23 http://sutent.legalview.com/msn/agennix-ag-shares-begin-trading-on-frankfurt-stock-exchange/1131342/ 2012-02-23 http://sutent.legalview.com/msn/phase-ii-study-of-sunitinib-in-men-with-advanced-prostate-cancer/1108464/ 2012-02-23 http://sutent.legalview.com/msn/novartis-delivers-strong-operational-performance-in-the-first-half-of/1108463/ 2012-02-23 http://sutent.legalview.com/msn/clinical-trial-at-the-cancer-institute-of-new-jersey-focuses-on-new/1108462/ 2012-02-23 http://sutent.legalview.com/msn/biotech-industry-veteran-k-peter-hirth-joins-alios-biopharma-board-of/1108461/ 2012-02-23 http://sutent.legalview.com/msn/cancer-drugs-may-treat-type-1-diabetes/1108460/ 2012-02-23 http://sutent.legalview.com/msn/pharmas-market-video/1108459/ 2012-02-23 http://sutent.legalview.com/msn/comments-about-go-away-palin-and-stay-away/1108458/ 2012-02-23 http://sutent.legalview.com/msn/postcode-lottery-of-cancer-treatment/1108457/ 2012-02-23 http://sutent.legalview.com/msn/biotech-industry-veteran-k-peter-hirth-joins-alios-biopharma-board-of/1108456/ 2012-02-23